SCHEMBL19933741

SCHEMBL19933741

Clc1ccc(-c2ccc(-c3ccc(-c4ccccc4-c4cc(-c5ccccc5-c5ccc(-c6ccccc6)nc5)cc(-c5ccccc5-c5ccc(-c6ccccc6)nc5)c4)cn3)cn2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.49
CTRC Q99895 1/20 0.49
LDHA P00338 1/20 0.47
CNR1 P21554 1/20 0.46
ALDH1A2 O94788 1/20 0.44
ALDH1A3 P47895 1/20 0.44
MAOB P27338 1/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
CYP1A2 P05177 1/20 0.44
HPGDS O60760 1/20 0.43
KMO O15229 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
BAZ2B Q9UIF8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015693 0.95 NPC1 (0.46) MAP4K4CTRCLDHACNR1ALDH1A2
SCHEMBL18573198 0.92 LDHA (0.45) MAP4K4CTRCLDHAALDH1A2ALDH1A3
SCHEMBL18015574 0.90 LDHA (0.52) LDHAHPGDSHSD17B1HSD17B2BAZ2B
SCHEMBL19933578 0.90 LDHA (0.52) LDHAHPGDSHSD17B1HSD17B2BAZ2B
SCHEMBL19933709 0.89 TGFBR1 (0.49) MAP4K4CTRCCNR1ALDH1A2ALDH1A3
SCHEMBL19794431 0.88 LDHA (0.50) LDHANPC1RAB9AHPGDSSMN1; SMN2
SCHEMBL18015495 0.88 LDHA (0.50) LDHANPC1RAB9AHPGDSSMN1; SMN2
SCHEMBL21721920 0.88 LDHA (0.50) LDHAHPGDSHSD17B1HSD17B2BAZ2B
SCHEMBL19794370 0.88 LDHA (0.50) LDHANPC1RAB9AHPGDSSMN1; SMN2
SCHEMBL21125931 0.86 HSD17B1 (0.56) LDHAHPGDSHSD17B1HSD17B2BAZ2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3507294-B1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-02-24 EP disclosed
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices MERCK PATENT GMBH 2021-01-12 US disclosed
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-07-04 US disclosed
WO-2018041769-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190202851-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES PARN, PUF60, PARG MAP4K4 3458/4885CTRC 3080/4885LDHA 2820/4885
US-10889604-B2 Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices PARN, PUF60, PARG MAP4K4 3458/4885CTRC 3080/4885LDHA 2820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.